Belgija – Farmacijos produktai – Framework contract for supply of Modified Vaccinia Ankara–Bavarian Nordic (MVA-BN®), a third-generation, non-replicating smallpox vaccine

Belgija – Farmacijos produktai – Framework contract for supply of Modified Vaccinia Ankara–Bavarian Nordic (MVA-BN®), a third-generation, non-replicating smallpox vaccine

I dalis: Perkančioji organizacija

I.1) Pavadinimas ir adresai:

Oficialus pavadinimas: European Commission, DG HERA - European Health Emergency Preparedness and Response Authority
Adresas: L-15 2/P097
Miestas: Brussels
Pašto kodas: B-1049
Šalis: Belgija
Asmuo ryšiams:
El-paštas: hera-joint-procurement-secretariat@ec.europa.eu
Interneto adresas (-ai):
Pagrindinis adresas: https://ec.europa.eu/info/strategy/priorities-2019-2024/promoting-our-european-way-life/european-health-union_en

II dalis: Objektas

II.1.1) Pavadinimas:

Framework contract for supply of Modified Vaccinia Ankara–Bavarian Nordic (MVA-BN®), a third-generation, non-replicating smallpox vaccine
Nuorodos numeris: EC-HERA/2025/NP/0003

II.1.2) Pagrindinis BVPŽ kodas:

33600000 Farmacijos produktai

II.1.3) Sutarties tipas:

Kita

II.1.4) Trumpas aprašymas:

Call for tender for the supply of Modified Vaccinia Ankara–Bavarian Nordic (MVA-BN®), a third-generation, non-replicating smallpox vaccine. Framework contract for supply of 8 000 000 (eight million) doses of mpox vaccines. There are 21 contracting authorities: European Commission (HERA), AT, BE, BG, CY, DK, EE, EL, ES, FR, HR, IE, LT, LU, MT, NL, NO, PL, RS, SI, SE

II.2) Aprašymas:

II.2.1) Kitas (-i) šio pirkimo BVPŽ kodas (-ai):

33600000 Farmacijos produktai